indian football team player Latest review: Stem cells are expected to become a new generation of treatments for neurological diseases The State Council requires deepening the reform of medical ...

Ideaya Biosciences ($IDYA) has taken investors on quite a ride this year. After the stock reached all-time highs in February, ...

As the new year looms, Harvey Jones is looking for the best share to buy in 2025. This FTSE 100 stock’s had a torrid year but ...

Jefferies Financial Group downgraded shares of GSK from a “buy” rating to a “hold” rating and reduced their price objective ...

discord id Adenosine-inhibiting tumor immune microenvironment regulating drugs (III): CD39 inhibitors Tigermed H-share issue price: HK$100/share, raising HK$10.7 billion R&D Daily丨GSK oligonucleotide ...

GSK plc (LON:GSK – Get Free Report) insider Jonathan Symonds bought 1,500 shares of the stock in a transaction on Friday, ...

With strong buy ratings and impressive growth, this FTSE 100 could soar in 2025. Here’s why Mark Hartley plans to invest in ...

When it comes to investing, Warren Buffett thinks it’s best to keep things simple. With Olympic diving, though, it’s a ...

Harvey Jones was looking forward to a Santa Rally in December, but it looks like we're not going to get one this year.

(Alliance News) - GSK PLC on Friday said a trial of two ovarian cancer treatments met its primary endpoint but did not meet a key secondary target. The First-Engot-OV44 phase III trial evaluated ...

Richard Saynor sees opportunity in copying cutting-edge medication and extols the merits of being boring. Richard Saynor ...

The global Pulmonary Arterial Hypertension (PAH) industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also ...